$154.83
-1.1-0.71%
At close: -
$154.83
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
The most recent guidance for Quest Diagnostics (DGX) was reported on October 22, 2024 for the full year 2024. The company provided earnings per share guidance in the range of $8.85 to $8.95, compared to the estimated EPS of $8.85. Additionally, Quest Diagnostics forecasted revenue between $9.80B and $9.85B for the quarter.
Browse guidance and forecast on all stocks.